Clear opportunity for Indian pharma firms to improve medicin

Report assessed the efforts of major generic and biosimilar medicine manufacturers like Hikma, Teva Viatris, Cipla, and Sun Pharma in expanding access to their essential products in low- and middle-income countries

Related Keywords

Netherlands , Helmsley , North Yorkshire , United Kingdom , Dutch , Jayasreek Iyer , Teva Viatris , Sun Pharma , Claudia Mart , Research Programme , Development Office , Cipla , Harryb Helmsley Charitable , Access To Medicine Foundation Generic , Biosimilar Medicines Programme , Dutch Ministry Of Foreign Affairs , Generic Biosimilar Medicines Programme , Access To Medicine Foundation , Medicine Foundation , Biosimilar Medicines , United Kingdom Foreign , Dutch Ministry , Foreign Affairs , Charitable Trust , These Indian , Chief Executive Officer , Research Programme Manager , Indian Pharma , Indian Pharma Sector ,